InvestorsHub Logo
Followers 20
Posts 5331
Boards Moderated 0
Alias Born 01/04/2012

Re: None

Tuesday, 11/07/2023 6:25:46 PM

Tuesday, November 07, 2023 6:25:46 PM

Post# of 14871
According to Mallinckrodt Earnings Release reported 2.9% drop in ACTHAR over last year. $122.1 million vs $125.7 million in Q3 2022.

Acthar® Gel (Repository Corticotropin Injection) Delivery Device Supplemental New Drug Application Accepted by U.S. Food and Drug Administration with a project launch in the second half of 2024.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ANIP News